Corline Biomedical AB

kr 12.95As of Sun 8 Nov 2026, 12:00 UTC
STO:CLBIOHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR 5.42%
Div yield —
ROE (13.72%)
Biotechnology
Beta (5Y) 0.30
PE TTM —
TSR TTM (34.60%)
Mkt cap kr 338.4M
ROIC (8.41%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 13
0.44%
(59.68%)
Buy 12|12|1|7|0
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.15
0.16
0.15
0.16
19.42%
24.17%
15.49%
17.40%
Revenuekr M
43.42
43.37
44.90
46.99
12.92%
9.47%
13.74%
13.60%
Peers (US$34.21M)
Cap (US$)
PE
34.74M
—
34.16M
76.75x
Capital
TTM
5Y
10Y
Leveragex
14.35
15.39
11.33
EBIT/Intx
0.144
0.332
0.242
Own earn%
60.26
(253.90)
(244.43)
Sh yield%
27.01
17.92
17.20
Owners
Insiders/Inst%
11.81
34.27
Short interest%
3.76
SBC / revenue%
2.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
13–26
$1 testx
—
Incr. ROIC%
5